Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 4, 2014, Pages 639-649

  Duthie, M S ^a   Guderian, J ^a   Vallur, A ^a   Bhatia, A ^a   Lima Dos Santos, P ^c   Vieira De Melo, E ^c   Ribeiro De Jesus, A ^c   Todt, M ^c   Mondal, D ^b   Almeida, R ^c   Reed, S G ^a  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^b ICDDRB Laboratory Sciences Division   (Bangladesh)

^c FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GELATINASE B; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 17; MEGLUMINE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; PROTOZOAL DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; DRUG EFFICACY; ETHNICITY; FEMALE; GEOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT RESPONSE; VISCERAL LEISHMANIASIS; YOUNG ADULT; ADOLESCENT; BLOOD; IMMUNOLOGY; LEISHMANIASIS, VISCERAL;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CYTOKINES; DNA, PROTOZOAN; FEMALE; HUMANS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84897091565     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1999-1     Document Type: Article

References (42)

1. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M; WHO Leishmaniasis Control Team (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671
2. Bacellar O, Brodskyn C, Guerreiro J, Barral-Netto M, Costa CH, Coffman RL, Johnson WD, Carvalho EM (1996) Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis. J Infect Dis 173:1515-1518 (Pubitemid 26286820)
3. Bacellar O, D'Oliveira A Jr, Jerônimo S, Carvalho EM (2000) IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine 12:1228-1231 (Pubitemid 30611800)
4. Carvalho EM, Bacellar O, Brownell C, Regis T, Coffman RL, Reed SG (1994) Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 152:5949-5956
5. Carvalho EM, Badaró R, Reed SG, Jones TC, Johnson WD Jr (1985) Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 76:2066-2069 (Pubitemid 16155495)
6. Cenini P, Berhe N, Hailu A, McGinnes K, Frommel D (1993) Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J Infect Dis 168:986-993 (Pubitemid 23282575)
7. Cillari E, Vitale G, Arcoleo F, D'Agostino P, Mocciaro C, Gambino G, Malta R, Stassi G, Giordano C, Milano S, Mansueto S (1995) In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis. Cytokine 7:740-745
8. Costa AS, Costa GC, Aquino DM, Mendonça VR, Barral A, Barral-Netto M, Caldas Ade J (2012) Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis. Mem Inst Oswaldo Cruz 107:735-739
9. de Oliveira FA, Vanessa Oliveira Silva C, Damascena NP, Passos RO, Duthie MS, Guderian JA, Bhatia A, de Moura TR, Reed SG, de Almeida RP, de Jesus AR (2013) High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis. BMC Infect Dis 13:331
10. Duffy T, Bisio M, Altcheh J, Burgos JM, Diez M, Levin MJ, Favaloro RR, Freilij H, Schijman AG (2009) Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients. PLoS Negl Trop Dis 3:e419
11. Elshafie AI, Hlin E, Håkansson LD, Elghazali G, Safi SH, Rönnelid J, Venge P (2011) Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis. Int J Parasitol 41:463-469
12. Gasim S, Elhassan AM, Khalil EA, Ismail A, Kadaru AM, Kharazmi A, Theander TG (1998) High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin Exp Immunol 111:64-69 (Pubitemid 28062778)
13. Ghalib HW, Piuvezam MR, Skeiky YA, Siddig M, Hashim FA, el-Hassan AM, Russo DM, Reed SG (1993) Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92:324-329 (Pubitemid 23209013)
14. Gidwani K, Picado A, Ostyn B, Singh SP, Kumar R, Khanal B, Lejon V, Chappuis F, Boelaert M, Sundar S (2011) Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India. Clin Vaccine Immunol 18:346-348
15. Hailu A (1990) Pre- and post-treatment antibody levels in visceral leishmaniasis. Trans R Soc Trop Med Hyg 84:673-675
16. Hailu A, van der Poll T, Berhe N, Kager PA (2004) Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis. Am J Trop Med Hyg 71:561-567 (Pubitemid 39601152)
17. Holaday BJ, Pompeu MM, Evans T, Braga DN, Texeira MJ, Sousa Ade Q, Sadick MD, Vasconcelos AW, Abrams JS, Pearson RD, Locksley RM (1993) Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi. J Infect Dis 167:411-417 (Pubitemid 23036444)
18. Holaday BJ, Pompeu MM, Jerônimo S, Texeira MJ, Sousa Ade A, Vasconcelos AW, Pearson RD, Abrams JS, Locksley RM (1993) Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest 92:2626-2632 (Pubitemid 24006526)
19. Louis H, Le Moine O, Goldman M, Devière J (2003) Modulation of liver injury by interleukin-10. Acta Gastroenterol Belg 66:7-14 (Pubitemid 36307052)
20. Machado de Assis TS, Rabello A, Werneck GL (2012) Predictive models for the diagnostic of human visceral leishmaniasis in Brazil. PLoS Negl Trop Dis 6:e1542
21. Maia Z, Lírio M, Mistro S, Mendes CMC, Mehta SR, Badaró R (2012) Comparative study of rK39 Leishmania antigen for serodiagnosis of visceral leishmaniasis: systematic review with meta-analysis. PLoS Negl Trop Dis 6:e1484
22. Maretti-Mira AC, de Pinho Rodrigues KM, de Oliveira-Neto MP, Pirmez C, Craft N (2011) MMP-9 activity is induced by Leishmania braziliensis infection and correlates with mucosal leishmaniasis. Acta Trop 119:160-164
23. McFarlane E, Perez C, Charmoy M, Allenbach C, Carter KC, Alexander J, Tacchini-Cottier F (2008) Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect Immun 76:532-541 (Pubitemid 351251723)
24. Mondal S, Bhattacharya P, Ali N (2010) Current diagnosis and treatment of visceral leishmaniasis. Expert Rev Anti Infect Ther 8:919-944
25. Oliveira LF, Schubach AO, Martins MM, Passos SL, Oliveira RV, Marzochi MC, Andrade CA (2011) Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop 118:87-96
26. Olliaro P, Sundar S (2009) Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India. Trop Med Int Health 14:88-92
27. Olliaro P, Vaillant MT, Sundar S, Balasegaram M (2012) More efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effects. PLoS Negl Trop Dis 6:e1545
28. Pattabhi S, Whittle J, Mohamath R, El-Safi S, Moulton GG, Guderian JA, Colombara D, Abdoon AO, Mukhtar MM, Mondal D, Esfandiari J, Kumar S, Chun P, Reed SG, Bhatia A (2010) Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis. PLoS Negl Trop Dis 4. pii: e822
29. Pedras MJ, de Gouvêa Viana L, de Oliveira EJ, Rabello A (2008) Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 102:172-178
30. Ridley RG (2007) Evaluating diagnostics: VL. Nat Rev Microbiol 5:S1
31. Sana G, Lombard C, Vosters O, Jazouli N, Andre F, Stephenne X, Smets F, Najimi M, Sokal EM (2013) Adult human hepatocytes promote CD4+ T cell hyporesponsiveness via interleukin-10 producing allogeneic dendritic cells. Cell Transplant
32. Schulz A, Mellenthin K, Schönian G, Fleischer B, Drosten C (2003) Detection, differentiation, and quantitation of pathogenic leishmania organisms by a fluorescence resonance energy transfer-based realtime PCR assay. J Clin Microbiol 41:1529-1535 (Pubitemid 36428100)
33. Singh OP, Gidwani K, Kumar R, Nylén S, Jones SL, Boelaert M, Sacks D, Sundar S (2012) Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin Vaccine Immunol 19:961-966
34. Srivastava P, Mehrotra S, Tiwary P, Chakravarty J, Sundar S (2011) Diagnosis of Indian visceral leishmaniasis by nucleic acid detection using PCR. PLoS One 6:e19304
35. Sundar S, Chakravarty J (2013) Leishmaniasis: an update of current pharmacotherapy. Expert Opin Pharmacother 14:53-63
36. Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW (2010) Single-dose liposomal amphotericin B for visceral leishmaniasis in India. N Engl J Med 362:504-512
37. Sundar S, Gupta LB, Rastogi V, Agrawal G, Murray HW (2000) Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis. Trans R Soc Trop Med Hyg 94:200-204 (Pubitemid 30307297)
38. Sundar S, Murray HW (2005) Availability of miltefosine for the treatment of kala-azar in India. Bull World Health Organ 83:394-395 (Pubitemid 40704871)
39. Sundar S, Rai M, Chakravarty J, Agarwal D, Agrawal N, Vaillant M, Olliaro P, Murray HW (2008) New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. Clin Infect Dis 47:1000-1006
40. van der Poll T, Zijlstra EE, Mevissen M (1995) Interleukin 6 during active visceral leishmaniasis and after treatment. Clin Immunol Immunopathol 77:111-114
41. Verma S, Kumar R, Katara GK, Singh LC, Negi NS, Ramesh V, Salotra P (2010) Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS One 5:e10107
42. World Health Organization (WHO) (2010) Leishmaniasis: burden of disease, surveillance & control, epidemics, access to medicines, information resources. Available online at: http://www.who.int/leishmaniasis/en/